Catalina Valencia
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Catalina Valencia
Catalina Valencia is recorded as Board Member at Axim Biotechnologies, Inc. (AXIM). Axim Biotechnologies, Inc. reported in an 8-K filed October 15, 2024 that Catalina Valencia was appointed Series C Director, effective October 14, 2024. Axim Biotechnologies, Inc. reported in an 8-K filed October 15, 2024 that Catalina Valencia was appointed President, effective October 9, 2024.
“effective October 14, 2024, Juniper, the record holder of all 500,000 shares of Series C Preferred Stock issued and outstanding, which shares are exclusively entitled to fill any vacancy of a Series C Director seat, appointed Catalina Valencia to fill the Series C Director vacancy that existed as a result of the death of John W. Huemoeller II.”
“on October 9, 2024, the Company’s board of directors appointed Catalina Valencia as the Company’s new President.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-10-14–present
-
Current
2024-10-09–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Axim Biotechnologies, Inc.
Other people whose current roles at this company are on record from its filings.
- Kurt Phinney COO
- Blake N. Schroeder Board Member
- Peter O'Rourke Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.